These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12906339)

  • 61. Design and evaluation of jingzhiguanxin monolithic osmotic pump tablet.
    Yang XG; Zhang GH; Li W; Peng B; Liu ZD; Pan WS
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):465-9. PubMed ID: 16595946
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design and in-vitro evaluation of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcellulose.
    Wang Z; Horikawa T; Hirayama F; Uekama K
    J Pharm Pharmacol; 1993 Nov; 45(11):942-6. PubMed ID: 7908033
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Production and
    Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
    Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M; Surana R; Sankar C; Mishra B
    Acta Pharm; 2003 Dec; 53(4):263-73. PubMed ID: 14769233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form.
    Haznar-Garbacz D; Kaminska E; Zakowiecki D; Lachmann M; Kaminski K; Garbacz G; Dorożyński P; Kulinowski P
    AAPS PharmSciTech; 2018 Feb; 19(2):951-960. PubMed ID: 29098644
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of zero-order controlled release preparations of nifedipine tablet on dissolution test, together with cost benefit point of view.
    Sakurai M; Naruto I; Matsuyama K
    Yakugaku Zasshi; 2008 May; 128(5):819-26. PubMed ID: 18451631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutically relevant blood pressure differences with two nifedipine (60 mg) osmotic delivery systems of differing design: three case reports.
    Pollak PT
    Int J Clin Pharmacol Ther; 2010 Jun; 48(6):400-4. PubMed ID: 20497748
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Clinical and pharmacokinetic comparison of 2 oral preparations of nifedipine: 10 mg capsules and 20 mg delayed-release tablets].
    Vidal-Gárate J; Castañeda Hernández G; Hoyo Vadillo C; Herrera Abarca JE; Salazar LA; Moreno Ramos A; Fortino Chávez J; Tena I; Hong E
    Arch Inst Cardiol Mex; 1989; 59(1):73-80. PubMed ID: 2486739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug.
    Avramoff A; Domb AJ
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):250-8. PubMed ID: 20353746
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development and optimization of buspirone oral osmotic pump tablet.
    Derakhshandeh K; Berenji MG
    Res Pharm Sci; 2014; 9(4):233-41. PubMed ID: 25657794
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
    Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
    Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs.
    Shokri J; Ahmadi P; Rashidi P; Shahsavari M; Rajabi-Siahboomi A; Nokhodchi A
    Eur J Pharm Biopharm; 2008 Feb; 68(2):289-97. PubMed ID: 17616378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.
    Andreas CJ; Tomaszewska I; Muenster U; van der Mey D; Mueck W; Dressman JB
    Eur J Pharm Biopharm; 2016 Aug; 105():193-202. PubMed ID: 27322002
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
    J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC.
    Ishikawa T; Watanabe Y; Takayama K; Endo H; Matsumoto M
    Int J Pharm; 2000 Jul; 202(1-2):173-8. PubMed ID: 10915941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.